232 related articles for article (PubMed ID: 24368849)
1. miR-218 opposes a critical RTK-HIF pathway in mesenchymal glioblastoma.
Mathew LK; Skuli N; Mucaj V; Lee SS; Zinn PO; Sathyan P; Imtiyaz HZ; Zhang Z; Davuluri RV; Rao S; Venneti S; Lal P; Lathia JD; Rich JN; Keith B; Minn AJ; Simon MC
Proc Natl Acad Sci U S A; 2014 Jan; 111(1):291-6. PubMed ID: 24368849
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-inducible miR-196a modulates glioblastoma cell proliferation and migration through complex regulation of NRAS.
Takkar S; Sharma V; Ghosh S; Suri A; Sarkar C; Kulshreshtha R
Cell Oncol (Dordr); 2021 Apr; 44(2):433-451. PubMed ID: 33469841
[TBL] [Abstract][Full Text] [Related]
3. p53 and miR-210 regulated NeuroD2, a neuronal basic helix-loop-helix transcription factor, is downregulated in glioblastoma patients and functions as a tumor suppressor under hypoxic microenvironment.
Agrawal R; Garg A; Benny Malgulwar P; Sharma V; Sarkar C; Kulshreshtha R
Int J Cancer; 2018 May; 142(9):1817-1828. PubMed ID: 29226333
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia enhances migration and invasion in glioblastoma by promoting a mesenchymal shift mediated by the HIF1α-ZEB1 axis.
Joseph JV; Conroy S; Pavlov K; Sontakke P; Tomar T; Eggens-Meijer E; Balasubramaniyan V; Wagemakers M; den Dunnen WF; Kruyt FA
Cancer Lett; 2015 Apr; 359(1):107-16. PubMed ID: 25592037
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-mediated mitochondria apoptosis inhibition induces temozolomide treatment resistance through miR-26a/Bad/Bax axis.
Ge X; Pan MH; Wang L; Li W; Jiang C; He J; Abouzid K; Liu LZ; Shi Z; Jiang BH
Cell Death Dis; 2018 Nov; 9(11):1128. PubMed ID: 30425242
[TBL] [Abstract][Full Text] [Related]
6. Feedback circuitry between miR-218 repression and RTK activation in glioblastoma.
Mathew LK; Huangyang P; Mucaj V; Lee SS; Skuli N; Eisinger-Mathason TS; Biju K; Li B; Venneti S; Lal P; Lathia JD; Rich JN; Keith B; Simon MC
Sci Signal; 2015 May; 8(375):ra42. PubMed ID: 25943352
[TBL] [Abstract][Full Text] [Related]
7. The HIF1α/HIF2α-miR210-3p network regulates glioblastoma cell proliferation, dedifferentiation and chemoresistance through EGF under hypoxic conditions.
Wang P; Yan Q; Liao B; Zhao L; Xiong S; Wang J; Zou D; Pan J; Wu L; Deng Y; Wu N; Gong S
Cell Death Dis; 2020 Nov; 11(11):992. PubMed ID: 33208727
[TBL] [Abstract][Full Text] [Related]
8. Bioinformatic analyses reveal a distinct Notch activation induced by STAT3 phosphorylation in the mesenchymal subtype of glioblastoma.
Cheng W; Zhang C; Ren X; Jiang Y; Han S; Liu Y; Cai J; Li M; Wang K; Liu Y; Hu H; Li Q; Yang P; Bao Z; Wu A
J Neurosurg; 2017 Jan; 126(1):249-259. PubMed ID: 26967788
[TBL] [Abstract][Full Text] [Related]
9. The plasticity of oncogene addiction: implications for targeted therapies directed to receptor tyrosine kinases.
Pillay V; Allaf L; Wilding AL; Donoghue JF; Court NW; Greenall SA; Scott AM; Johns TG
Neoplasia; 2009 May; 11(5):448-58, 2 p following 458. PubMed ID: 19412429
[TBL] [Abstract][Full Text] [Related]
10. Multiple receptor tyrosine kinases converge on microRNA-134 to control KRAS, STAT5B, and glioblastoma.
Zhang Y; Kim J; Mueller AC; Dey B; Yang Y; Lee DH; Hachmann J; Finderle S; Park DM; Christensen J; Schiff D; Purow B; Dutta A; Abounader R
Cell Death Differ; 2014 May; 21(5):720-34. PubMed ID: 24440911
[TBL] [Abstract][Full Text] [Related]
11. Mir-370-3p Impairs Glioblastoma Stem-Like Cell Malignancy Regulating a Complex Interplay between HMGA2/HIF1A and the Oncogenic Long Non-Coding RNA (lncRNA) NEAT1.
Lulli V; Buccarelli M; Ilari R; Castellani G; De Dominicis C; Di Giamberardino A; D Alessandris QG; Giannetti S; Martini M; Stumpo V; Boe A; De Luca G; Biffoni M; Marziali G; Pallini R; Ricci-Vitiani L
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443824
[TBL] [Abstract][Full Text] [Related]
12. Annexin A2-STAT3-Oncostatin M receptor axis drives phenotypic and mesenchymal changes in glioblastoma.
Matsumoto Y; Ichikawa T; Kurozumi K; Otani Y; Fujimura A; Fujii K; Tomita Y; Hattori Y; Uneda A; Tsuboi N; Kaneda K; Makino K; Date I
Acta Neuropathol Commun; 2020 Apr; 8(1):42. PubMed ID: 32248843
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-378 enhances radiation response in ectopic and orthotopic implantation models of glioblastoma.
Li W; Liu Y; Yang W; Han X; Li S; Liu H; Gerweck LE; Fukumura D; Loeffler JS; Yang BB; Jain RK; Huang P
J Neurooncol; 2018 Jan; 136(1):63-71. PubMed ID: 29081036
[TBL] [Abstract][Full Text] [Related]
14. The role of factor inhibiting HIF (FIH-1) in inhibiting HIF-1 transcriptional activity in glioblastoma multiforme.
Wang E; Zhang C; Polavaram N; Liu F; Wu G; Schroeder MA; Lau JS; Mukhopadhyay D; Jiang SW; O'Neill BP; Datta K; Li J
PLoS One; 2014; 9(1):e86102. PubMed ID: 24465898
[TBL] [Abstract][Full Text] [Related]
15. miRNA-124-3p/neuropilin-1(NRP-1) axis plays an important role in mediating glioblastoma growth and angiogenesis.
Zhang G; Chen L; Khan AA; Li B; Gu B; Lin F; Su X; Yan J
Int J Cancer; 2018 Aug; 143(3):635-644. PubMed ID: 29457830
[TBL] [Abstract][Full Text] [Related]
16. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
[TBL] [Abstract][Full Text] [Related]
17. microRNA-558 facilitates the expression of hypoxia-inducible factor 2 alpha through binding to 5'-untranslated region in neuroblastoma.
Qu H; Zheng L; Song H; Jiao W; Li D; Fang E; Wang X; Mei H; Pu J; Huang K; Tong Q
Oncotarget; 2016 Jun; 7(26):40657-40673. PubMed ID: 27276678
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-124 expression counteracts pro-survival stress responses in glioblastoma.
Mucaj V; Lee SS; Skuli N; Giannoukos DN; Qiu B; Eisinger-Mathason TS; Nakazawa MS; Shay JE; Gopal PP; Venneti S; Lal P; Minn AJ; Simon MC; Mathew LK
Oncogene; 2015 Apr; 34(17):2204-14. PubMed ID: 24954504
[TBL] [Abstract][Full Text] [Related]
19. Analysis of angiogenesis related factors in glioblastoma, peritumoral tissue and their derived cancer stem cells.
D'Alessio A; Proietti G; Lama G; Biamonte F; Lauriola L; Moscato U; Vescovi A; Mangiola A; Angelucci C; Sica G
Oncotarget; 2016 Nov; 7(48):78541-78556. PubMed ID: 27705944
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-7 targets T-Box 2 to inhibit epithelial-mesenchymal transition and invasiveness in glioblastoma multiforme.
Pan CM; Chan KH; Chen CH; Jan CI; Liu MC; Lin CM; Cho DY; Tsai WC; Chu YT; Cheng CH; Chuang HY; Chiu SC
Cancer Lett; 2020 Nov; 493():133-142. PubMed ID: 32861705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]